Astraveus announces the appointment of Dr. Lars Henrik Peeck as Chief Business Development Officer.
Dr Peeck's career spans over 12 years in pharma process innovation, marked by a distinguished history of business and R&D leadership responsibilities.
His experience includes overseeing more than two dozen launches of industry leading products and successfully managing three technology company acquisitions, showcasing his proficiency in strategic integrations, business transformation and growth initiatives.
Prior to joining Astraveus, Dr Peeck served as Senior Director and Head of R&D for Upstream and Process & Materials at Merck Life Science KGaA in Darmstadt, Germany.
There, he led a global R&D organization focused on developing new bioprocess materials, cell culture media, expression systems, excipients and APIs for pharmaceutical development and GMP manufacturing.
His strategic leadership supported key portfolio areas within Merck´s Process Solutions business, indicating his proven ability to drive innovation and growth in competitive markets.
As Chief Business Development Officer at Astraveus, Dr Peeck will be responsible for driving strategic partnerships, identifying new market opportunities and expanding the company's presence in the CGT manufacturing field.
With Dr Peeck's transformational leadership capabilities and pharma processing expertise, Astraveus is well-positioned to achieve its vision of democratising access to cell and gene therapies and delivering groundbreaking solutions that will benefit countless patients worldwide.
Jérémie Laurent, Founder and Chief Executive Officer of Astraveus, said: "Lars brings a comprehensive set of relevant experience and interpersonal skills that make him the ideal person to lead our business development efforts as we continue to advance our Lakhesys platform and roll it out in the CGT manufacturing ecosystem. We are confident that his leadership will play a pivotal role in shaping the future of our company."
Dr Lars Henrik Peeck, Chief Business Development Officer of Astraveus, commented: "Astraveus is at the forefront of a transformative industry and I am excited to be part of a team with such an ambitious vision."
"Together, we will further advance the development of the Lakhesys platform and work towards making these life-changing therapies more accessible to patients in need."
